UNSPSC 51453003: Pexantel

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HOH9HJ2737. European Medicines Agency schedules Pexantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09740MIG. Pexantel generally arises in the molecular formula C12H22N2O.

The term PEXANTEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, no. 11 1970, list 10.) PEXANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pexantel under HS 29335995 and SITC 51576. As of Q4 2014, PEXANTEL remains the US FDA Preferred Term for this commodity. Pexantel bears US NLM identifiers UMLS ID C1882353 and NCI Concept Code C66362. SMILES: O=C(N1CCN(CC1)C)C1CCCCC1.

UNSPSC 51453003 Pexantel (Commodity) covers pharmaceutical products, but the recent state and local opportunities tagged under this code show minimal alignment with pexantel specifically — the two recent awards center on naloxone and safe drug deactivation systems, and on doxycycline hyclate and ciprofloxacin hydrochloride tablets through a piggyback pharmaceutical warehouse contract. State and local health departments and county public health agencies are the primary issuing bodies, using cooperative purchasing consortia (MMCAP Infuse) and direct competitive bidding (IFB) to source emergency response and infectious disease pharmaceuticals in bulk quantities. The opportunities reflect state and county procurement focused on community health initiatives, emergency preparedness, and disease control rather than the specific pharmaceutical this code nominally describes.

The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (IFB 26-482DPH-PREPD-B-53392) for warehouse supply of doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets. Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026 with a July 26, 2023 response deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the county community health building and FEMA-potential funding. Recent activity is concentrated in Florida and Illinois, though the small sample size and code-scope mismatch limits confidence in geographic characterization. The code shows little relevant recent activity aligned to pexantel procurement.